Reducing Health Inequities Through Total Knee Arthroplasty: An Experience From Bhutan
- PMID: 39935844
- PMCID: PMC11810982
- DOI: 10.1002/hsr2.70459
Reducing Health Inequities Through Total Knee Arthroplasty: An Experience From Bhutan
Abstract
Background and aims: Bhutan is a low-middle-income country with a 0.7 million population with a high burden of musculoskeletal conditions. Recognizing the high burden of osteoarthritis, total knee arthroplasty (TKA) was launched in the country in 2022. However, Bhutan continues to refer complicated cases to India. In 2024, International Operation, a US-based nonprofit secular and humanitarian organization, conducted a TKA camp in Bhutan. This perspective aims to report about the camp and discuss how such camps help reduce healthcare disparities.
Method: We compiled data on patients who underwent total knee or hip arthroplasty in last 7 years from the registry maintained at National Referral Hospital of Bhutan. We shared our experience of hosting TKA camp and discuss how such camps might help reduce healthcare disparities.
Result: In last 7 years, Bhutan referred increasing number of patients for total knee and hip arthroplasty to India. Royal Government of Bhutan spends Nu. 250,000 (approximately US$3000) per patient excluding expenses for travel, logistics, and medications. A team from International Operation conducted TKA on 31 patients during the camp.
Conclusion: Such camps would help reduce the healthcare disparities in low- and middle-income countries.
Keywords: health equities; osteoarthritis; surgical camp; total knee arthroplasty.
© 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Ministry of Health ., “Royal Government of Bhutan,” Annual Health Bulletin 2023. (Thimphu, 2023).
-
- Steinmetz J. D., Culbreth G. T., Haile L. M., et al., “Global, Regional, and National Burden of Osteoarthritis, 1990–2020 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021,” The Lancet Rheumatology 5, no. 9 (2023): e508–e522, 10.1016/s2665-9913(23)00163-7. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
